Single Dose, Single Administration Study of Technosphere Inhalation Powder in Diabetic Subjects With Mild or Moderate Kidney Disease Compared to Diabetic Subjects With Normal Kidney Function

NCT00626249 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Nephropathy
Moderate Nephropathy
Diabetes Mellitus

Interventions

DRUG: Technosphere Inhalation Powder

Sponsor

Mannkind Corporation